These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 33763031

  • 21. Case Report: Nodule Development From Subcapsular Aldosterone-Producing Cell Clusters Causes Hyperaldosteronism.
    Nishimoto K, Seki T, Kurihara I, Yokota K, Omura M, Nishikawa T, Shibata H, Kosaka T, Oya M, Suematsu M, Mukai K.
    J Clin Endocrinol Metab; 2016 Jan; 101(1):6-9. PubMed ID: 26580238
    [Abstract] [Full Text] [Related]

  • 22. Cellular and Genetic Causes of Idiopathic Hyperaldosteronism.
    Omata K, Satoh F, Morimoto R, Ito S, Yamazaki Y, Nakamura Y, Anand SK, Guo Z, Stowasser M, Sasano H, Tomlins SA, Rainey WE.
    Hypertension; 2018 Oct; 72(4):874-880. PubMed ID: 30354720
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Overview of aldosterone-related genetic syndromes and recent advances.
    Zennaro MC, Fernandes-Rosa FL, Boulkroun S.
    Curr Opin Endocrinol Diabetes Obes; 2018 Jun; 25(3):147-154. PubMed ID: 29432258
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Pathology and gene mutations of aldosterone-producing lesions.
    Nishimoto K, Ogishima T, Sugiura Y, Suematsu M, Mukai K.
    Endocr J; 2023 Dec 28; 70(12):1113-1122. PubMed ID: 37766569
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Pathophysiology of bilateral hyperaldosteronism.
    Nanba K, Rainey WE.
    Curr Opin Endocrinol Diabetes Obes; 2022 Jun 01; 29(3):233-242. PubMed ID: 35621175
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. WNT/β-catenin signalling is activated in aldosterone-producing adenomas and controls aldosterone production.
    Berthon A, Drelon C, Ragazzon B, Boulkroun S, Tissier F, Amar L, Samson-Couterie B, Zennaro MC, Plouin PF, Skah S, Plateroti M, Lefèbvre H, Sahut-Barnola I, Batisse-Lignier M, Assié G, Lefrançois-Martinez AM, Bertherat J, Martinez A, Val P.
    Hum Mol Genet; 2014 Feb 15; 23(4):889-905. PubMed ID: 24087794
    [Abstract] [Full Text] [Related]

  • 35. Adrenal cortex remodeling and functional zona glomerulosa hyperplasia in primary aldosteronism.
    Boulkroun S, Samson-Couterie B, Dzib JF, Lefebvre H, Louiset E, Amar L, Plouin PF, Lalli E, Jeunemaitre X, Benecke A, Meatchi T, Zennaro MC.
    Hypertension; 2010 Nov 15; 56(5):885-92. PubMed ID: 20937967
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. An update on novel mechanisms of primary aldosteronism.
    Zennaro MC, Boulkroun S, Fernandes-Rosa F.
    J Endocrinol; 2015 Feb 15; 224(2):R63-77. PubMed ID: 25424518
    [Abstract] [Full Text] [Related]

  • 39. Polymorphic variation of CYP11B2 predicts postoperative resolution of hypertension in patients undergoing adrenalectomy for aldosterone-producing adenomas.
    Wang W, Hu WL, Zhang LC, Xiao YS, Liu J, Bin C.
    Int J Urol; 2012 Sep 15; 19(9):813-20. PubMed ID: 22650983
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.